Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|October 15, 2013
Interleukin 18: friend or foe in cancerGiuseppe Palma, Antonio Barbieri, Sabrina Bimonte, et al.
Anti-Cancer Drugs|January 27, 2015
Vemurafenib beyond progression in a patient with metastatic melanoma: a case reportAntonio M Grimaldi, Ester Simeone, Marco Palla, et al.
Journal of Translational Medicine|October 16, 2009
Main roads to melanomaGiuseppe Palmieri, Mariaelena Capone, Maria Libera Ascierto, et al.
Oncoimmunology|April 14, 2017
Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanomaEster Simeone, Antonio Maria Grimaldi, Lucia Festino, et al.
Future Oncology (London, England)|May 7, 2020
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE studyPaolo Bossi, Ketty Peris, Piergiacomo Calzavara-Pinton, et al.
Journal of Translational Medicine|April 27, 2017
Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysisGianluca Di Monta, Corrado Caracò, Ester Simeone, et al.
BMC Dermatology|August 17, 2010
The role of spectrophotometry in the diagnosis of melanomaPaolo A Ascierto, Marco Palla, Fabrizio Ayala, et al.
The Journal of Dermatological Treatment|September 3, 2020
Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implicationsVictor Desmond Mandel, Matelda Medri, Ausilia Maria Manganoni, et al.
Pageof 4